|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 133.21 USD | -0.80% |
|
130.46 | -2.07% |
| Jul. 16 | Kalshi to allow bets on clinical trials, FDA decisions | RE |
| Jul. 15 | African markets - factors to watch on July 15 | RE |
| Market Cap | 165B 145B 134B 123B 233B 15,949B 236B 1,602B 628B 7,803B 621B 607B 26,885B | P/E 2026 * |
-48x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 175B 153B 142B 130B 246B 16,861B 250B 1,694B 664B 8,250B 657B 642B 28,423B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 5.11x |
| Free-Float |
99.88% | Yield 2026 * |
2.44% | Yield 2027 * | 2.52% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -0.80% | ||
| 1 week | +1.38% | ||
| Current month | +5.44% | ||
| 1 month | +7.64% | ||
| 3 months | -1.96% | ||
| 6 months | +7.31% | ||
| Current year | +8.53% |
| 1 week | 129.4 |  | 140.61 |
| 1 month | 123 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.06 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 71 | 2020-10-16 |
| Director/Board Member | 73 | 2017-12-31 | |
Ted Love
BRD | Director/Board Member | 67 | 2024-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 7/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +1.38% | +23.09% | +66.64% | 167B | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,051B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 609B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 450B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 330B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 223B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 198B | |
| -1.20% | +1.10% | +1.14% | -32.69% | 143B | |
| Average | -0.80% | -0.03% | +24.34% | +39.50% | 371.78B | |
| Weighted average by Cap. | -0.90% | -0.99% | +33.94% | +66.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.46B 26.7B 24.68B 22.7B 42.83B 2,938B 43.52B 295B 116B 1,437B 114B 112B 4,952B | 32.32B 28.33B 26.19B 24.08B 45.44B 3,117B 46.17B 313B 123B 1,525B 121B 119B 5,254B |
| Net income | -3.39B -2.97B -2.75B -2.53B -4.77B -327B -4.84B -32.85B -12.88B -160B -12.73B -12.46B -551B | 9.76B 8.56B 7.91B 7.27B 13.72B 941B 13.94B 94.57B 37.07B 461B 36.66B 35.86B 1,587B |
| Net Debt | 9.46B 8.29B 7.66B 7.05B 13.3B 912B 13.51B 91.65B 35.93B 446B 35.52B 34.75B 1,538B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | $133.21 | -0.80% | 4,103,028 |
| 26-07-17 | $134.28 | -1.48% | 6,903,235 |
| 26-07-16 | $136.30 | +3.49% | 7,926,819 |
| 26-07-15 | $131.70 | +1.28% | 4,467,637 |
| 26-07-14 | $130.04 | -1.04% | 5,255,960 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
